The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content



KNIGHT THERAPEUTICS Inc closed up Friday by $0.04 or 0.49% to $8.17. Shares have lost 0.61% over the last five days, but have gained 5.83% over the last year to date. This security has outperformed the S&P TSX by 23.30% during the last year.

Key company metrics

  • Trailing P/E38.03×
  • P/E 1 year forward58.95×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.21
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Total other revenue--------
Total revenue1000
Gross profit1000
Total cost of revenue0000
Total operating expense-2-8-6-7
Selling / general / administrative2222
Research & development0020
Depreciation / amortization0000
Interest expense (income), net operating--000
Unusual expense (income)0000
Other operating expenses, total-1-10-1
Operating income3978
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax3978
Income after tax0669
Income tax, total330-1
Net income0669
Total adjustments to net income--------
Net income before extra. items0669
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items0669
Inc. avail. to common incl. extra. items0669
Diluted net income0669
Dilution adjustment--------
Diluted weighted average shares1041049693
Diluted EPS excluding extraordinary itemsvalue per share0.
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share0.